Is a complete LON/0RHR research report available?

No complete published report is available for lon/0RHR (LON/0RHR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

lon/0RHR stock profile: metrics, valuation and analysis

Market cap	673.3M
Revenue (ttm)	131.8M
Net income (ttm)	6.8M
EPS (ttm)	CHF 0.16
P/E (trailing)	99.6x
P/E (forward)	79.1x
Volume	29,800
Beta	0.76

All LON/0RHR indicators

Market & fundamental data

Available fields

151

Groups with data

Currency

USD

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	178
Employees Change	56%
Employees Change Percent	45.9
Enterprise value	CHF 659.8M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	CH0325814116
Last refreshed	2026-09-08
Market cap	CHF 673.3M
Price	CHF 18.43
Price currency	CHF
Rev Per Employee	740,709.26x
Sector	Healthcare
Sector PE	21.59
Sector PE Fwd	13.78
Sic	2836
Symbol	lon/0RHR
Website	https://kurosbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1%
EV Earnings	97.6x
EV/EBIT	84.21x
EV/EBITDA	63.13x
EV/Sales	5.11x
Forward P/E	79.12x
P/E ratio	99.59x
P/S ratio	5.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.07%
EBITDA Margin	7.65%
Gross margin	86.37%
Gross Profit	CHF 113.9M
Gross Profit Growth	38.66%
Gross Profit Growth Q	41.95%
Gross Profit Growth3 Y	102.03%
Gross Profit Growth5 Y	93.77%
Net Income	CHF 6.8M
Net Income Growth Qo Q	-3.48%
Net Income Growth Quarters	2%
Net Income Growth Years	3%
Pretax Margin	6.15%
Profit Margin	5.13%
Profit Per Employee	CHF 37,977
Profitable Quarters	CHF 2
Profitable Years	1
Roa5y	-2.41
Roe5y	-9.76
ROIC	7.8
Roic5y	-7.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.78%
Cagr1y	-32.5%
Cagr3y	98.11%
Cagr5y	48.24%
EPS Growth Qo Q	1.99
EPS Growth Quarters	2
EPS Growth Years	3
Revenue Growth	42.45x
Revenue Growth Q	45.49x
Revenue Growth Qo Q	11.84x
Revenue Growth Quarters	15x
Revenue Growth Years	8x
Revenue Growth3 Y	102.57x
Revenue Growth5 Y	83.45x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
WACC	8.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	9.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-7.52%
1Y total return	-32.48%
200-day SMA	23.71
3Y total return	677.87%
50-day SMA	21.09
50-day SMA vs 200-day SMA	50under200
5Y total return	615.57%
All Time High	34.08
All Time High Change	-48.77%
All Time High Date	2025-10-20
All Time Low	1.28
All Time Low Change	1,264.06%
All Time Low Date	2023-03-16
ATR	1
Beta	0.76
Ch YTD	-36.52
High	18.43
High52	34.08
High52 Date	2025-10-20
High52ch	-45.93%
Low	17.32
Low52	17.32
Low52 Date	2026-09-07
Low52ch	6.41%
Ma50ch	-17.21%
Price vs 200-day SMA	-26.35%
RSI	27.87
RSI Monthly	44.29
RSI Weekly	37.09
Sharpe ratio	-0.53x
Sharpe Ratio3y	0.65x
Sortino ratio	-0.67
Sortino Ratio3y	1.16
Total Return	9.33%
Tr YTD	-36.52
Tr1m	-24.22%
Tr1w	-15.96%
Tr3m	-15.32%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	29,383,808%
Shares Insiders	25.94%
Shares Institutions	22.58%
Shares Qo Q	-5.81%
Shares Yo Y	-9.33%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	23,204.1x
Ch10y	-25.3
Ch1m	-24.22
Ch1w	-15.96
Ch1y	-32.48
Ch3m	-15.32
Ch3y	677.7
Ch5y	615.6
Ch6m	-37.01
Change	2.95%
Change From Open	5.31
Close	17.9
Days Gap	-2.23
Depreciation Amortization	2,040,696.6
Dollar Volume	549,214
Earnings Date	2026-08-13
EBIT	CHF 8M
EBITDA	CHF 10.1M
EPS	CHF 0.16
F Score	1
Fiscal Year End	December
Founded	2,016
Income Tax	CHF 1.4M
Is Primary Listing	0
Last Earnings Date	2026-08-13
Last Report Date	2026-06-30
Ma150	22.26
Ma150ch	-21.55%
Ma20	21.1
Ma20ch	-17.24%
Next Earnings Date	2026-12-03
Open	17.5
Position In Range	100
Price Date	2026-09-07
Price EBITDA	CHF 66.76
Relative Volume	1.28x
Revenue	131,846,248x
Tax By Revenue	1.06x
Tax Rate	17.23%
Tr6m	-37.01%
Volume	29,800

LON/0RHR (LON/0RHR)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0RHR

Valuation

Profitability

Trading

Next earnings

Sector percentile context

All LON/0RHR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0RHR

Frequently asked questions